At the completion of this activity, the participant will be able to:
1. Discuss the epidemiology, pathophysiology, diagnosis, prognostic factors, and staging of chronic lymphocytic leukemia
2. Define indications for treatment initiation and options for first-line therapy
3. Review mechanisms of resistance and their influence on subsequent-line therapy options
4. Recall the pharmacology of available therapeutic agents
5. Recognize supportive care strategies for patients receiving treatment for chronic lymphocytic leukemia